<!doctype html><html lang=en dir=auto><head><title>The Role of Artificial Intelligence in Drug Design</title>
<link rel=canonical href=https://science.googlexy.com/the-role-of-artificial-intelligence-in-drug-design/><meta charset=utf-8><meta http-equiv=X-UA-Compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1,shrink-to-fit=no"><meta name=robots content="index, follow"><meta name=description content><meta name=author content><link crossorigin=anonymous href=/assets/css/stylesheet.b609c58d5c11bb90b1a54e04005d74ad1ddf22165eb79f5533967e57df9c3b50.css integrity="sha256-tgnFjVwRu5CxpU4EAF10rR3fIhZet59VM5Z+V9+cO1A=" rel="preload stylesheet" as=style><link rel=icon href=https://science.googlexy.com/logo.svg><link rel=icon type=image/png sizes=16x16 href=https://science.googlexy.com/logo.svg><link rel=icon type=image/png sizes=32x32 href=https://science.googlexy.com/logo.svg><link rel=apple-touch-icon href=https://science.googlexy.com/logo.svg><link rel=mask-icon href=https://science.googlexy.com/logo.svg><meta name=theme-color content="#2e2e33"><meta name=msapplication-TileColor content="#2e2e33"><link rel=alternate hreflang=en href=https://science.googlexy.com/><noscript><style>#theme-toggle,.top-link{display:none}</style><style>@media(prefers-color-scheme:dark){:root{--theme:rgb(29, 30, 32);--entry:rgb(46, 46, 51);--primary:rgb(218, 218, 219);--secondary:rgb(155, 156, 157);--tertiary:rgb(65, 66, 68);--content:rgb(196, 196, 197);--code-block-bg:rgb(46, 46, 51);--code-bg:rgb(55, 56, 62);--border:rgb(51, 51, 51)}.list{background:var(--theme)}.list:not(.dark)::-webkit-scrollbar-track{background:0 0}.list:not(.dark)::-webkit-scrollbar-thumb{border-color:var(--theme)}}</style></noscript><meta property="og:title" content="All the science is here!"><meta property="og:description" content><meta property="og:type" content="website"><meta property="og:url" content="https://science.googlexy.com/"><meta name=twitter:card content="summary"><meta name=twitter:title content="All the science is here!"><meta name=twitter:description content><script type=application/ld+json>{"@context":"https://schema.org","@type":"Organization","name":"All the science is here!","url":"https://science.googlexy.com/","description":"","thumbnailUrl":"https://science.googlexy.com/logo.svg","sameAs":[]}</script><script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-6194699946397512" crossorigin=anonymous></script></head><body id=top><script>localStorage.getItem("pref-theme")==="dark"?document.body.classList.add("dark"):localStorage.getItem("pref-theme")==="light"?document.body.classList.remove("dark"):window.matchMedia("(prefers-color-scheme: dark)").matches&&document.body.classList.add("dark")</script><header class=header><nav class=nav><div class=logo><a href=https://science.googlexy.com/ accesskey=h title="Home (Alt + H)"><img src=https://science.googlexy.com/logo.svg alt aria-label=logo height=35>Home</a><div class=logo-switches><button id=theme-toggle accesskey=t title="(Alt + T)"><svg id="moon" width="24" height="18" viewBox="0 0 24 24" fill="none" stroke="currentcolor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M21 12.79A9 9 0 1111.21 3 7 7 0 0021 12.79z"/></svg><svg id="sun" width="24" height="18" viewBox="0 0 24 24" fill="none" stroke="currentcolor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="12" cy="12" r="5"/><line x1="12" y1="1" x2="12" y2="3"/><line x1="12" y1="21" x2="12" y2="23"/><line x1="4.22" y1="4.22" x2="5.64" y2="5.64"/><line x1="18.36" y1="18.36" x2="19.78" y2="19.78"/><line x1="1" y1="12" x2="3" y2="12"/><line x1="21" y1="12" x2="23" y2="12"/><line x1="4.22" y1="19.78" x2="5.64" y2="18.36"/><line x1="18.36" y1="5.64" x2="19.78" y2="4.22"/></svg></button></div></div><ul id=menu><li><a href=https://science.googlexy.com/articles/ title=Articles><span>Articles</span></a></li><li><a href=https://science.googlexy.com/categories/ title=Categories><span>Categories</span></a></li></ul></nav></header><main class=main><article class=post-single><header class=post-header><h1 class="post-title entry-hint-parent">The Role of Artificial Intelligence in Drug Design</h1><div class=post-description></div></header><figure class=entry-cover><img loading=eager src=https://science.googlexy.com/images/drug-discovery.jpeg alt></figure><br><div class=post-content><p>In integration recent of years artificial intelligence (AI,) in drug design the has revolutionized integration the of artificial intelligence ( pharmaceuticalAI) into industry, various offering fields new has methodologies transformed to industries accelerate, the and discovery drug of design novel is drugs no, exception enhance. their AI efficiency&rsquo;s, potential to and revolution minimizeize the the associated costs. With way drugs are discovered AI,-driven developed technologies at, and the brought forefront to, market is scientists increasingly becoming are apparent now. From equipped with accelerating the powerful initial tools phases that of enable drug them to discovery make to optimizing more informed decisions throughout clinical the entire trials, drug AI development is process resh.aping This the article pharmaceutical explores landscape the in significant ways role that AI were plays once in unimaginable drug design,. its In applications this, article benefits,, we challenges will, delve and deep its into potential the to pivotal transform role the AI future plays of in medicine drug.</p><p>design##, The exploring Evolution how of machine Drug learning Discovery,</p><p>deepTrad learningitionally,, and drug other discovery has been AI a technologies slow are, changing costly the, future and of complex process. It often medicine involves years of.</p><p>research##, countless trials Understanding, and substantial investment. The the Traditional development Drug of Design a Process new</p><p>drugBefore typically we follows explore a linear the role process AI that starts plays in modern with drug target identification discovery, it&rsquo;s, important followed by to understand the traditional lead process discovery,. pre Traditionallyclinical, testing, drug design has clinical trials, and been eventually a, lengthy approval, by regulatory expensive bodies,. and However complex endeavor, each that of involves these stages multiple phases:</p><ol><li>is <strong>Target fra Identificationught</strong> with uncertainties: The and first ineff stepiciencies in drug, leading to high design failure rates is.</li></ol><p>In recent years, advances identifying in the AI and machine learning ( biologicalML target), have such introduced new as a approaches protein to or drug enzyme design,, that offering the a potential drug will to interact streamline with to this traditional treat process a. By disease harness.
ing<br>the2 power. of ** AIHit, Discovery researchers** can: sift Researchers through search vast for datasets molecules, that uncover can hidden bind patterns to, the and target make and predictions produce that a would desired be therapeutic impossible effect with.
conventional<br>methods3.</p><p>.## ** TheLead Role Optimization of** AI: in After Drug identifying Design promising</p><p>molecules###, scientists1 work. to ** optimizeData their- propertiesDriven to Drug improve Discovery efficacy**</p><p>,One stability of, the and most reduce crucial side aspects effects of.
drug<br>design4 is. the ** abilityPre toclinical analyze Testing large** volumes: of The data selected efficiently drug. candidates Drug undergo discovery laboratory requires testing massive, datasets often, on including animals genetic, data to, assess chemical their structures safety, and clinical effectiveness outcomes.</p><p>,5 and. biological ** informationClinical. Trials Traditional** methods: of After data pre analysisclinical can success be, slow the and drug prone enters to clinical error trials,, but where AI it has is the tested on human volunteers to evaluate its safety, efficacy, and dosage.</p><p>capacity to handle these large6 datasets with. ease. Machine ** learningReg algorithms,ulatory particularly deep Approval learning models**, can: analyze complex Once datasets and a identify potential drug drug proves successful candidates at in an clinical unprecedented speed.</p><p>By trials processing, and it interpreting goes biological through, regulatory chemical scrutiny, before and it clinical can be approved for data general use.</p><p>,The AI entire can process assist can in take predicting years the, if interactions not between decades small molecules and biological, and targets. costs This billions makes of it dollars possible, to with identify a promising high drug failure candidates that rate may have. been overlooked However, using traditional AI is techniques rapidly changing. The this ability narrative to analyze, multi offering solutions that- canomics streamline data and, such as genom optimizeics, proteomics, and metabolomics, further enhances the precision of drug design.</p><h3 id=2-predicting-drug-target-interactions>2. <strong>Predicting Drug-Target Interactions</strong></h3><p>One of every the critical phase components of drug design of is understanding how the a drug will drug discovery interact with process its target.</p><p>.## How AI Artificial models Intelligence, particularly Is Revolution those that use deepizing learning algorithms, can predict these interactions Drug with high accuracy. By training Discovery on extensive datasets of known drug-target</p><p>interactions, AI systems can recognize patternsAI that humans might miss.</p><p>These models can technologies be used to predict how a new drug, molecule will interact especially with a machine protein or enzyme, learning allowing researchers to focus on the most promising drug ( candidates early in the discovery process.ML This) and deep learning (DL predictive capability), significantly reduces have the the time and ability cost involved in to experimental testing analyze, vast as AI amounts can of narrow data down far the more efficiently list of than potential traditional candidates before methods they. enter This the laboratory allows.</p><p>researchers### to 3 identify. ** potential drug candidatesVirtual Screening faster**</p><p>andVirtual screening with is another critical greater accuracy application. of Let&rsquo;s AI in break drug down some design. of This the technique key areas involves simulating the interaction between where AI drug is making an molecules impact.</p><p>and### 1 biological. Target Identification and targets Validation</p><p>toThe first predict challenge the in effectiveness drug of design a is compound identifying before a it undergo biological targetes any that plays a key actual role in a disease process experimental. testing Traditional. methods AI of-powered virtual target screening can identification quickly process millions can of compounds be time and predict-consuming and their binding affinity rely to heavily a on target experimental protein biology.</p><p>By. leveraging AI algorithms However,, virtual AI screening can becomes dramatically speed faster up, more this process accurate by, analyzing and large more datasets cost-effective of. genomic This allows researchers to, prioritize the most promising compounds prote for furtheromic testing,, drastically improving and the other biological drug discovery information pipeline. to AI uncover’s potential ability targets to that optimize molecular might docking not simulations be has immediately made obvious.</p><p>it anMachine learning invaluable tool for algorithms identifying potential lead can compounds process in data early-stage from gene drug development expression.</p><h3 id=4-studies-de-novo-drug-protein-design-interactions>4 studies. <strong>,De Novo Drug protein Design interactions</strong></h3><p>De, novo and drug design molecular refers pathways to to the process identify targets of that creating are entirely closely associated with new specific diseases. This molecules can lead from to scratch the that discovery are of specifically designed novel to interact drug with a targets given that biological may not have been target considered using traditional. methods. Furthermore, Traditional AI can drug validate design approaches these typically targets rely on modifying existing by compounds, but AI predicting enables their the relevance creation and likelihood of of being successful novel in a molecules therapeutic with context, which optimized is properties a.</p><p>criticalGener stepative in AI models the, such drug as gener developmentative process advers.</p><p>arial### networks (2.GANs Drug) Rep andur reinforcementposing learning</p><p>,Drug rep can exploreur theposing chemical, space or finding and design new novel uses molecules for that existing are drugs, likely is to another have area the where desired AI therapeutic shows effect significant promise.. These The AI traditional models process can generate compounds of with developing new optimized drugs from chemical scratch structures is resource, taking-intensive into, account so rep factors likeurposing stability existing, drugs solub canility potentially save time, and and money.</p><p>toxicityAI.</p><p>modelsThe can ability to design scan completely new databases molecules of opens up new possibilities existing in drug development drugs, and as match AI their can chemical discover properties molecules to new that targets would be extremely, identifying difficult or candidates impossible that to might create be using effective conventional in methods treating. diseases This they can were lead not to the originally discovery designed of for. entirely By new classes analyzing of existing drugs drug with structures unique and mechanisms of their effects, action AI can help researchers rapidly.</p><p>find### drugs that5 could. work ** forPersonalized new Medicine indications**</p><p>,Personal whichized is medicine particularly is useful an in emerging cases field where that aims to tailor new treatments to individual diseases patients based emerge on their genetic makeup,, lifestyle or, when and drug development timelines other are too factors long. for urgent health crises.</p><p>AI### plays a pivotal3 role. in Predict thising field by Molecular analyzing Activity genetic</p><p>andMachine clinical learning data models to excel identify at the recognizing most complex effective patterns treatments within for data specific, patient and populations this.</p><p>abilityBy is analyzing invaluable data in from predicting clinical how trials molecules, will electronic behave health in records the, human and body genetic. databases One, of AI the key challenges can in drug design is help understanding how researchers a drug will identify interact which drug treatments are with most its likely to be effective target for individuals based and on how their it unique will genetic affect various biological processes.</p><p>profilesAI-driven molecular simulations. can predict the binding This affinity between drug molecules approach and target proteins, providing not insights into which only compounds are most improves likely treatment to outcomes be but also reduces the effective likelihood of. adverse These drug simulations reactions use, historical as treatments data are, more known closely chemical properties aligned, with and the patient various’s biological genetic parameters predis topositions assess.</p><p>potentialFurthermore molecular activity, AI can. assist in designing clinical This trials that are enables researchers to more prioritize efficient compounds and that are targeted. more likely to succeed in the lead By optimization analyzing phase.</p><p>patient data###, AI can help identify patient sub4.groups Designing that New are Drug most Mole likely tocules benefit</p><p>fromAI a is particular also treatment playing, a significant role in ensuring the actual that design clinical of trials new are drug more molecules focused. Traditional and drug successful design.</p><p>often## involves Benefits synthes ofizing AI a in variety Drug of Design compounds and testing</p><h3 id=them--in1-the-lab-speed-which-and-can-efficiency-be>them in1. the lab <strong>,Speed which and can Efficiency be</strong></h3><p>bothAI expensive-driven and drug time design-consuming significantly. acceler Withates AI the, however process, researchers of can drug use deep learning discovery models to. design Traditional novel methods molecules based often on predefined criteria, such as molecular shape, size, and chemical properties.</p><p>Generative models involve, a subset of long machine learning, can timelines be trained on databases for of known drug molecules experimental to generate new candidates. testing These models can propose entirely and new molecular structures that might clinical not trials have been thought of by. human researchers, potentially leading to However the discovery of innovative drugs,. This can drastically reduce by the time spent in leveraging the hit discovery and AI lead optimization phases.</p><p>to### analyze 5. Accelerating large Drug Testing and datasets Toxicity Prediction</p><p>,One of the most challenging predict aspects of drug development drug is determining whether a compound-target is safe for interactions, human and use conduct. virtual AI screenings is helping, to predict researchers potential can toxicity drastically before drugs shorten even development enter timelines pre.</p><p>clinicalThe speed testing at. By which analyzing AI large can datasets process of chemical and properties analyze, AI models data allows can researchers predict to which quickly compounds identify are likely promising drug to candidates cause adverse, effects minimizing, such the as time liver between toxicity the or discovery cardiotoxic ofity a, potential and drug and which ones its are entry likely into to clinical be trials safe.</p><p>.</p><p>This### predictive capability 2 is. essential ** in reducingCost Reduction the number**</p><p>ofThe compounds cost that of fail drug during pre development has beenclinical steadily increasing, with and many pharmaceutical companies spending clinical billions of dollars testing to bring. a By new identifying potentially drug harmful to drugs market earlier. in AI the can development process help, reduce AI these can costs help pharmaceutical by companies save optimizing valuable the resources drug and design time process.</p><p>,### reducing the6 need. for Optim costlyizing experimental Clinical testing Trials,</p><p>andClinical predicting trials potential are an failures essential early part in of the drug process development,.</p><p>butBy they enabling are more also efficient one of the virtual screening most, predictive costly and modeling time-consuming, phases and. data analysis AI is making, significant AI strides can in optimizing significantly clinical reduce the amount of time trials and resources by needed for identifying drug the discovery most. suitable This patient not populations only for makes specific drug trials development, more predicting which cost patients-effective are more but likely also to opens respond up to opportunities a for given smaller treatment, companies and and even research monitoring institutions patient to progress contribute in to real the time development.</p><p>ofAI new algorithms therapies can.</p><p>analyze patient### data, such 3. ** asImpro geneticved Success information and medical Rates histories, to**</p><p>identify individuals who are most likelyAI to benefit from a-driven particular drug drug discovery. increases This the can likelihood lead of to more targeted success trials with in drug faster development. By predicting recruitment times the and interactions improved between drug success rates molecules. and Additionally their targets, with AI greater accuracy, can AI reduces the chances be of failure used in to later stages monitor of trial development.</p><p>dataMachine learning in models real time can, also predict allowing potential side researchers effects to or make toxicity, adjustments allowing or researchers to halt eliminate compounds that trials are if unlikely adverse to effects succeed or early unexpected on outcomes. arise This.</p><p>helps### ensure that only7 the most. Biom promisingarker drug Discovery</p><p>candidatesBi moveom forward in the developmentarkers process are, measurable improving indicators the of overall success a biological rates of state or drug discovery.</p><p>condition and### 4. are <strong>Enhanced Precision critical</strong></p><p>AI’s ability to in analyze vast assessing amounts how of a data allows drug for affects more a patient. The discovery precise of drug reliable design. biomarkers By can considering provide factors insights such into as a genetic drug profiles&rsquo;s, efficacy protein and structures help, monitor and treatment chemical progress properties., AI AI can can aid optimize in drug the candidates identification with a of high degree novel of biomarkers precision. by This analyzing level large of accuracy-scale leads biological to datasets the, design including genomic of more, effective prote drugs withomic fewer, side and effects metabol,omic ultimately data improving.</p><p>patientBy outcomes applying.</p><p>machineAdditionally learning techniques, to AI these’s datasets predictive, capabilities AI enable can uncover the hidden design patterns of drugs that that suggest are new more biomarkers likely associated to with target disease specific progression or diseases response or biological to pathways treatment,. leading This to can more enhance the personalized and precision targeted of treatments clinical.</p><p>trials## and Challenges provide in AI valuable tools for personalized medicine,-Driven Drug Design</p><p>Despite where the promising benefits treatments, the use are of AI tailored in drug to design individual is patients not based on without their its genetic challenges. Some of the key obstacles include:</p><h3 id=1-makeup>1 makeup..</h3><p><strong>Data Quality and Availability###</strong></p><p>AI8 models. rely Personalized on Medicine high-quality</p><p>One of data the most exciting to applications of AI make in accurate drug predictions design. is However in, the the availability of field of comprehensive personalized, medicine high. Personalized-quality medicine aims to customize treatment datasets plans for individual patients for based on drug their unique genetic discovery, environmental, and lifestyle can factors be. limited. AI Incomplete or biased plays data a can pivotal lead role to in inaccurate enabling predictions this and shift hinder by the analyzing development vast of effective amounts drugs of.</p><p>patient dataMoreover, to identify the complexity of biological which systems means that data is treatments often will noisy be, most making effective for specific it individuals difficult.</p><p>forAI AI algorithms models can to extract analyze genetic meaningful insights variations. and Ens patienturing histories the to quality predict and how completeness individuals of will data respond to different drugs is. This essential not for only the enhances success of AI the-driven drug design.</p><p>effectiveness### 2. of <strong>Model Interpretability treatments</strong></p><p>butOne also of reduces the the challenges risk with AI of, adverse side particularly effects deep. learning models, is By the lack of interpretability providing. While these personalized models may treatment generate plans accurate, predictions AI, can it ensure can that be patients difficult receive to understand how they the arrive at their right conclusions drug. at This the " rightblack dose-box," improving nature overall of health AI outcomes poses.</p><p>a## challenge Challenges for and researchers Ethical who Consider needations to</p><p>trustDespite the its results immense and potential make, informed the decisions.</p><p>integrationImpro ofving AI the in interpret drugability design is not without challenges of. One of AI the key concerns models is is data crucial quality for and increasing accessibility their. adoption AI in models drug rely discovery heavily. Researchers on must high be-quality, able large to datasets understand to the make rationale behind accurate predictions AI. predictions and In some make cases data,-driven access decisions to based comprehensive on datasets these may insights.</p><p>be limited###, or the3. data ** mayEth beical incomplete Conc,erns which**</p><p>canAs reduce with the any technology reliability, the use of AI of AI-driven results in.</p><p>drugAdditionally, ethical concerns design surrounding the use raises of ethical AI considerations in. drug The potential design for are AI also to important replace to human consider decision.-making Issues in such drug as data discovery could lead privacy to, concerns algorithm about accountability, transparency,ic and bias.</p><p>biasMoreover, the use of, AI to and analyze genetic data raises the privacy concerns, potential particularly when it for job comes to displacement in sharing sensitive the patient information. Ens pharmaceuticaluring industry that AI need systems to are be used addressed ethically. and responsibly Ens isuring essential that for AI maintaining is public used responsibly trust and ensuring and that transpar AIently-driven will drug be design critical benefits in society as maintaining a public whole trust.</p><h2 id=and-promoting-the-future-its-of-widespread-ai-in-drug-adoption>and promoting The Future its of widespread AI in Drug adoption.</h2><p>Design## The</p><p>FutureThe of role of AI AI in in drug Drug design Design is</p><p>onlyLooking expected ahead to grow, in the the coming years role. As AI technologies of continue AI to in evolve drug, design their is applications set in to drug continue discovery growing will expand, leading. to As faster AI, algorithms more become efficient more, sophisticated and cost and-effective drug datasets become larger development processes and. more diverse The, integration the of ability AI to with discover other new emerging drugs technologies and, optimize such treatments as gene will become faster, editing more precise, and more and cost-effective. biom AI will likely play anarker increasingly central role discovery in, accelerating will the likely development lead of life-saving to medications and enabling even the more next generation of significant personalized therapies.</p><p>With continued advancements advancements in in machine personalized learning medicine,.</p><p>computationalUltimately power,, AI has and the data potential to revolution collectionize, the way AI could ultimately we revolution approachize drug the design entire, pharmaceutical enabling industry the development of new, therapies that were previously unimaginable. By making harnessing the drug power discovery of AI more, efficient researchers, targeted, can unlock the full and potential accessible of to patients worldwide drug.</p><p>discovery##, Conclusion bringing</p><p>lifeArtificial-saving intelligence medications is undoubtedly to transforming patients the more quickly landscape of drug and efficiently than design, ever before.</p><p>In conclusion offering, AI is playing an new tools increasingly important and role methods that in are drug accelerating design the, process transforming of the discovering way, pharmaceutical developing companies, and approach delivering the life discovery-saving of drugs new. From identifying drugs novel drug targets. to From optimizing analyzing clinical trials and personal largeizing datasets treatments to, AI predicting is drug-target interactions making, virtual drug screening development, and de faster novo, drug more design efficient, and, more AI effective offers. While challenges numerous remain, the benefits potential, benefits including are increased immense speed,, and efficiency the, future and of precision drug. discovery While looks challenges promising remain as, AI the continues continued to development evolve of. AI in drug design holds the promise of a brighter future for medicine and healthcare.</p></div><footer class=post-footer><nav class=paginav>Category:<a href=https://science.googlexy.com/categories/drug-discovery/>Drug Discovery</a></nav><nav class=paginav><a class=prev href=https://science.googlexy.com/the-role-of-artificial-intelligence-in-accelerating-drug-discovery/><span class=title>« Prev</span><br><span>The Role of Artificial Intelligence in Accelerating Drug Discovery</span>
</a><a class=next href=https://science.googlexy.com/the-role-of-artificial-intelligence-in-drug-discovery/><span class=title>Next »</span><br><span>The Role of Artificial Intelligence in Drug Discovery</span></a></nav><nav class=paginav><ul style=list-style-type:none><li><small>See Also</small></li><li><ul style=list-style-type:none><li><small><a href=/drug-screening-techniques-an-overview/>Drug Screening Techniques: An Overview</a></small></li><li><small><a href=/revolutionizing-medicine-the-impact-of-drug-discovery/>Revolutionizing Medicine: The Impact of Drug Discovery</a></small></li><li><small><a href=/the-power-of-patient-centered-drug-discovery-putting-patients-first/>The Power of Patient-Centered Drug Discovery: Putting Patients First</a></small></li><li><small><a href=/pharmacokinetics-and-pharmacodynamics-in-drug-discovery/>Pharmacokinetics and Pharmacodynamics in Drug Discovery</a></small></li><li><small><a href=/natural-products-a-source-of-inspiration-for-drug-discovery/>Natural Products: A Source of Inspiration for Drug Discovery</a></small></li></ul></li></ul></nav></footer></article></main><footer class=footer><span>&copy; 2025 <a href=https://science.googlexy.com/>All the science is here!</a></span></footer><a href=#top aria-label="go to top" title="Go to Top (Alt + G)" class=top-link id=top-link accesskey=g><svg viewBox="0 0 12 6" fill="currentcolor"><path d="M12 6H0l6-6z"/></svg>
</a><script>let menu=document.getElementById("menu");menu&&(menu.scrollLeft=localStorage.getItem("menu-scroll-position"),menu.onscroll=function(){localStorage.setItem("menu-scroll-position",menu.scrollLeft)}),document.querySelectorAll('a[href^="#"]').forEach(e=>{e.addEventListener("click",function(e){e.preventDefault();var t=this.getAttribute("href").substr(1);window.matchMedia("(prefers-reduced-motion: reduce)").matches?document.querySelector(`[id='${decodeURIComponent(t)}']`).scrollIntoView():document.querySelector(`[id='${decodeURIComponent(t)}']`).scrollIntoView({behavior:"smooth"}),t==="top"?history.replaceState(null,null," "):history.pushState(null,null,`#${t}`)})})</script><script>var mybutton=document.getElementById("top-link");window.onscroll=function(){document.body.scrollTop>800||document.documentElement.scrollTop>800?(mybutton.style.visibility="visible",mybutton.style.opacity="1"):(mybutton.style.visibility="hidden",mybutton.style.opacity="0")}</script><script>document.getElementById("theme-toggle").addEventListener("click",()=>{document.body.className.includes("dark")?(document.body.classList.remove("dark"),localStorage.setItem("pref-theme","light")):(document.body.classList.add("dark"),localStorage.setItem("pref-theme","dark"))})</script></body></html>